Talk about selecting and employing people
Release time:
2020-08-14
Talking about Selecting and Employing People
Throughout the ages, selecting and employing people has been a very difficult thing. For enterprises, what kind of people to manage the enterprise is the most important and critical of all work. It is related to the sustainable and stable development of the enterprise and even the success or failure of the enterprise. The sixth Plenary session of the 18th CPC Central Committee put forward: "adhering to the correct orientation of selecting and employing personnel is the organizational guarantee for serious inner-party political life." It is clearly stated that the selection and appointment of cadres must adhere to the principle of having both ability and political integrity and putting morality first. Good cadres should have the character of seeking truth from facts, appointing people on their merits, being honest and honest, and daring to take responsibility. In view of how to select and employ people in the actual work of enterprises, I think the following aspects should be seriously considered.
1. should choose fair and decent people
"the key to politics is to win people". Adhering to the cadre line of appointing people on their merits and the employment standard of having both ability and political integrity and putting morality first is inseparable from the four words of "fairness and decency". Both the candidates and the candidates must follow this principle. Meritocracy is both a sign and a guarantee of fairness and decency. The standards that must be followed by fair and decent candidates with both ability and political integrity and morality as the first are an important manifestation of the core concept of fairness and decency. A person's fairness and decency is not innate, but a habit slowly accumulated in long-term work practice, and a concentrated reflection of a person's moral conduct. When we select and employ people, we should pay attention to his words and deeds in peacetime, and it is the cadres and masses at the grass-roots level who really understand his usual work performance. Therefore, we must listen carefully to opinions when selecting and appointing people, and on the basis of the full recognition of the grassroots cadres and the masses, we must choose the best leaders.
2. career as the top priority, and do not stick to one pattern in selecting and employing people
career as the top priority is to take the interests of the party and the interests of the enterprise as the top priority in actual work, to be conscientious, steadfast and dare to take responsibility. Not sticking to one pattern is to correct the bias of selecting people only in terms of sales, age and diploma. In the process of selecting and appointing people, we must exclude those who put personal interests above collective interests and would rather harm the interests of the enterprise than suffer a little loss from the cadre team. We cannot simply think that as long as the benefits go up, everything will be fine; let alone that as long as the sales go up, everything will be fine. The short-term benefits can not truly reflect the profitability of the enterprise, and the sales can not mean that everything is better. If there are a lot of bad debts and dead debts, a lot of unsalable goods in stock, long-term accounts are not dealt with, and the company's management is lax and people's hearts are separated. Such "benefits" and "sales" can not explain anything, but there are all kinds of harm but no benefit. Therefore, when we select and employ people, it is important to see if they can bring sustained, stable and healthy development to the enterprise. Cadres should be younger and more knowledgeable. Knowledge is not about how high their diplomas are, and rejuvenation does not mean that every team must be equipped with a young person. It still depends on political quality, professionalism, comprehensive quality, and the ability to solve problems.
3. should pay more attention to the moral investigation of the training objects and outstanding talents
. Generally speaking, talented people are popular. They are easy to approach the favorite people. If they approach more, they will naturally believe. If they believe for a long time, they will easily spoil the letter and be full-time. Therefore, those who examine the talents are easy to be deceived by their talents and forget to examine their moral character, this is a very dangerous thing. From ancient times to the present, the disorderly officials of the country and the prodigal son of the family, because of the surplus of talent but the lack of virtue, have led to the collapse of the country and the decline of the family. Today, it is also a truth for enterprises to select and employ people. If we only focus on talents and ignore moral examination, or mistake sharp and rude management as bold management, we are not afraid of offending people; or if we detain the protection and benefits that employees should get, when we become enterprises for the sake of making profits for enterprises, then we will make mistakes. Once talented and immoral people are selected to important leadership positions, it will cause fatal harm to enterprises. Therefore, the more talented people are in the selection and employment of people, the more attention should be paid to the investigation of their moral character, so that they can make good choices, or use their strengths or avoid their weaknesses, so as to ensure both ability and political integrity to the maximum extent, and provide the most important guarantee for the healthy and sustainable development of enterprises. (Jinhua pharmaceutical co., ltd. party branch yuan Jie)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31